Aquaculture Healthcare Market Size By Product (Drug {Parasiticides, Anti-inflammatory, Anti-infectives}, Vaccines {Modified Live Vaccines (MLV), Killed Inactivated Vaccines}, Medicated Feed Additives {Antibiotics, Vitamins, Amino Acids, Enzymes, Antioxidants, Prebiotics and Probiotics, Minerals, Hormones}), By Species (Fish {Freshwater Species [Tilapia, Carp], Marine Species [Sea Bass, Sea Bream, Turbot], Diadromous Species [Salmon, Trout]}, Crustaceans {Prawns, Shrimps}), By Infections (Bacterial Infections, Viral Infections, Parasitic Infections, Fungal Infections), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Distributors, Online Stores, Retail/Aqua Stores), Regional Outlook, Price Trends, Application Potential, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Feb 2020  |  Report ID: GMI4536  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 420   |   Base Year: 2019

Summary Table of Contents Industry Coverage Methodology

Industry trends

Aquaculture Healthcare Market size exceeded USD 730 million in 2019 and is projected to achieve over 5.8% CAGR during 2020 to 2026.

Aquaculture Healthcare Market

Get more details on this report - Request Free Sample PDF

The growing aquaculture business has contributed to the rise of aquaculture healthcare industry. The crustacean segment will see rapid growth over the forecast period owing to the high production from Asia Pacific region. The large crustacean business in the Asia Pacific region presents a lucrative opportunity for the companies. This will lead to a rise in therapeutics for crustaceans.

Aquaculture, also known as fish farming, is the practice of rearing aquatic animals such as fish and crustaceans under controlled conditions. Emphasis of aquaculture healthcare is increasing owing to rising incidence of various infectious diseases. This can be attributed to the crowded growth conditions and poor quality of nutrition and water. However, major players are involved in development of advanced vaccines that will control the infectious diseases.

Rising demand for fish protein across the world will boost the market growth

Fish is consumed all over the world and is a good source of protein and micronutrients. According to Food and Agriculture Organization (FAO), the consumption of fish has doubled to 20 kg per capita in 2016 and is rising. This growing demand for quality fish has led to overfishing and depletion of wild fisheries, propelling the market for farmed fish. A growing aquaculture market has positively impacted the demand for aquaculture healthcare products. Hence, a rising demand for fish protein globally will spur the aquaculture healthcare market demand.

However, concerns over antibiotic use regarding the development of antibiotic resistant bacterial strains might dampen the market growth over the forecast period. Furthermore, a lack of knowledge regarding the diseases and aquaculture healthcare will restrict the industry expansion in the short term.

Focus on healthy fish production will contribute to the expansion of vitamins segment

Aquaculture Healthcare Market

Get more details on this report - Request Free Sample PDF

The product segment is categorized into drugs, vaccines, and medicated feed additives. The medicated feed additives segment was valued at USD 129.2 million in 2019 and will see substantial growth over the forecast period. Medicated feed additives include antibiotics, vitamins, amino acids, enzymes, antioxidants, prebiotics & probiotics, minerals, and hormones.

Vitamins segment accounted for market revenue share of 17.9% in 2019. Vitamins and amino acids are vital to ensure optimal growth of aquatic animals. Furthermore, growing emphasis on healthy produce of fish to increase the economic benefits will boost the demand of vitamins for aquaculture healthcare.


Global demand for salmon and tilapia to make fishes the star segment

The fish segment accounted for market share of more than 85% in 2019 and will witness robust growth over the analysis timeframe. Global demand for fish, the diversity of species in the fish segment will make it the market leading segment.

Fishes are further classified into freshwater, marine and diadromous depending on the waterbody of habitat. Freshwater species contain tilapia and carps, while the marine species are sea bass, sea bream, and turbot. Diadromous species sub-segment includes salmon and trout.

The developed countries, especially in the Atlantic region have conducive conditions for rearing salmon, boosting the demand for aquaculture healthcare products for salmon. Moreover, the demand for salmon and tilapia products is increasing in Western European and North American region. These factors will contribute to segment expansion, and in turn impact the market progress.

Therapeutics for viral infections will witness rapid growth due to high pervasiveness of viral infections

Aquaculture healthcare market by infections is segmented into bacterial, viral, parasitic and fungal infections based on the causative agent. The viral infections segment is poised to exhibit 6.1% CAGR over the forecast period. The high growth can be attributed to incidence of viral diseases because of presence of viruses such as aquabirnavirus, betanodavirus, and salmon anemia virus.

These viruses cause various symptoms such as necrosis, disfigurement of fish, and often result in 100% mortality of the population. Viruses present a significant challenge in aquaculture healthcare as viral infections lead to loss in fish production, leading to huge economic losses. These factors will push the segment expansion, boosting the industry growth.

Ease of use will bolster the expansion of oral therapeutics segment

Aquaculture Healthcare Market Share

Get more details on this report - Request Free Sample PDF

Oral therapeutics segment was valued at USD 53.4 million in 2015 and held about 10% market revenue share in 2019. Ease of use of oral therapeutics will contribute to the market demand. Furthermore, high demand for medicated feed additives that require oral administration will propel the segment expansion. Thus, above mentioned factors will contribute to segment growth and aquaculture healthcare market growth.

Distributors will see substantial growth due to growing agreements with the manufacturers

By distribution channel the market is segmented into distributors, online stores, and retail/aqua stores. Distributors segment accounted for revenue of USD 293.8 million in 2019. This is due to majority of the manufacturers are signing agreements and partnerships with distributors to increase the product outreach. Moreover, distributors have a widespread network in various developing and developed markets. These factors will contribute to the growth of the distributors segment, fostering the industry expansion.

Shrimp farming will propel the Asia Pacific aquaculture healthcare market revenue

Asia Pacific held a substantial market share in 2019 of about 27.7% and will witness a 6.6% CAGR over the forecast timeframe. Thailand, India, China, and Indonesia have the biggest crustacean markets in the globe. This will boost the demand for therapeutic products for crustaceans. Furthermore, growing awareness regarding importance of aquaculture healthcare will serve to boost the product demand. This will in turn propel the regional aquaculture healthcare industry.

The European market accounted for revenue of USD 319.9 million in 2019 and will see robust growth during the future. Growing demand for quality fish protein and the large salmon aquaculture market will serve to boost the demand for aquaculture healthcare solutions. Additionally, advanced rearing techniques used in the European region will drive the need for sophisticated therapeutics. These factors will positively impact the regional aquaculture healthcare industry.

Novel product launches by leading industry players will drive market demand

Major industry players in the aquaculture healthcare market share are Elanco, Zoetis, DuPont, Vetoquinol, Ceva Sante, Benchmark PLC, and Archer Daniels Midland Corporation. The key players are focusing on research & development to launch innovative aquaculture healthcare products. Strategic acquisitions remain another strategy to expand their customer base.

Recent industry developments:

  • In February 2018, PharmaQ, a subsidiary of Zoetis announced launch of vaccine against Viral Nervous Necrosis (VNN) for sea bass in Spain, Italy, Croatia and Greece. This launch enabled the company to strengthen its market presence in Europe and expand its customer base.
  • In August 2016, Elanco launched Imvixa, an innovative delousing solution to treat sea lice in salmon. This launch has helped the company increase their sales and revenue generation from aquaculture healthcare.

The aquaculture healthcare market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

Aquaculture Healthcare Market, By Product, 2015 – 2026 (USD Million)

  • Drug
    • Parasiticides
    • Anti-inflammatory
    • Anti-infectives
    • Others
  • Vaccines
    • Modified live vaccines [MLV]
    • Killed inactivated vaccines
    • Others
  • Medicated feed additives
    • Antibiotics
    • Vitamins
    • Amino acids
    • Enzymes
    • Antioxidants
    • Prebiotics and probiotics
    • Minerals
    • Hormones
    • Others

Aquaculture Market, By Species, 2015 – 2026 (USD Million)

  • Fishes
    • Freshwater Species
      • Tilapia
      • Carps
      • Others
    • Marine Species
      • Sea bass
      • Sea bream
      • Turbot
      • Others
    • Diadromous Species
      • Salmon
      • Trout
      • Others
  • Crustaceans
    • Prawns
    • Shrimps
    • Others

Aquaculture Market, By Infections, 2015 – 2026 (USD Million)

  • Bacterial infections
  • Viral infections
  • Parasitic infections
  • Fungal infections

Aquaculture Pharmaceuticals Market, By Route Of Administration, 2015 – 2026 (USD Million)

  • Oral
  • Injectable
  • Topical

Aquaculture Pharmaceuticals Market, By Distribution Channel, 2015 – 2026 (USD Million)

  • Distributors
  • Online stores
  • Retail/aqua stores
  • Others

The above information is provided for the following geographies:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Denmark
    • Iceland
    • Ireland
    • Norway
    • Poland
    • Turkey
    • Others
  • Asia Pacific
    • China
    • Vietnam
    • Indonesia
    • India
    • Thailand
    • Bangladesh
    • Philippines
    • Australia
    • New Zealand
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Chile
    • Others
  • Middle East and Africa
    • Iran
    • Egypt
    • Others

Frequently Asked Questions (FAQ) :

The market size of aquaculture healthcare crossed USD 730 million in 2019.
The industry share of aquaculture healthcare is expected to expand at 5.8% CAGR during 2020 to 2026.
The medicated feed additives segment was valued at USD 129.2 million in 2019, says a GMI report.
The viral infections segment is expected to grow at 6.1% CAGR over during 2020-2026 owing to incidence of viral diseases because of presence of viruses such as aquabirnavirus, betanodavirus, and salmon anemia virus.
The fish species segment is projected to account for more than 85% aquaculture healthcare market share in 2026, driven by global demand for fish and the diversity of fish species.
The Asia Pacific aquaculture pharmaceuticals market held a substantial revenue in 2019 of 27.7% and will witness a 6.6% CAGR over the forecast timeframe.

Premium Report Details

  • Published Date: Feb 2020
  • Pages: 420
  • Tables: 830
  • Charts / Figures: 19
  • Companies covered: 10
  • Countries covered: 27

Get a report that explains COVID-19 impact on this market

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X